Alcami Corporation

𝗛𝗼𝘄 𝗰𝗮𝗻 𝗼𝗻𝗲 𝗯𝗹𝗶𝘀𝘁𝗲𝗿 𝘀𝘁𝗼𝗰𝗸 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗺𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝗺𝗮𝗿𝗸𝗲𝘁𝘀? Tomorrow, Pieter Vercruysse, Senior Director, Commercial Operations at Alcami Corporation, will join the Outsourced Pharma Capabilities Update on Oral Solid Dose Formulation to share insights into late-stage blister customization. Pieter will explore how postponement packaging enables pharmaceutical companies to maintain market-neutral blister stock and apply approved, market-specific information once demand is confirmed. The presentation will cover how this approach can help companies: 🔹 Respond more quickly to changing market demand 🔹 Support multiple markets and flexible order volumes 🔹 Reduce inventory risk and waste from obsolete packaging 📅 August 18, 2026 ⏰ 1:00 PM ET ➡️ Register through the link in the comments to learn how delaying market commitment can create a more responsive, efficient and reliable pharmaceutical supply chain. #OralSolidDose #PharmaceuticalPackaging #PostponementPackaging #SupplyChain

⚡ When measuring a fast signal, the measurement system needs to be even faster. Rise time indicates how quickly a signal transitions from low to high—but if an oscilloscope, cable or connection is too slow, it can distort the waveform and make the measured rise time appear longer than it actually is. For calibrators such as the Fluke 5522A, which can generate edges with rise times of 300 picoseconds or less, a typical bench oscilloscope may not provide the accuracy required. Alcami uses a 20 GHz oscilloscope to support reliable measurement across the complete test setup, including cables, adapters and connections. We are now expanding our electrical calibration capabilities to include high-speed pulse measurements on multifunction calibrators—giving customers access to a broader range of calibration services through a single trusted provider. Need support with high-speed pulse measurements or multifunction calibrator calibration? Contact our team to discuss your equipment and service requirements. #Calibration #ElectricalCalibration #Metrology #TestAndMeasurement #PharmaceuticalManufacturing

𝐈𝐬 𝐩𝐡𝐚𝐫𝐦𝐚 𝐨𝐮𝐭𝐬𝐨𝐮𝐫𝐜𝐢𝐧𝐠 𝐦𝐨𝐯𝐢𝐧𝐠 𝐛𝐞𝐲𝐨𝐧𝐝 𝐭𝐡𝐞 𝐨𝐧𝐞-𝐬𝐭𝐨𝐩-𝐬𝐡𝐨𝐩 𝐦𝐨𝐝𝐞𝐥? In a new Pharma's Almanac roundtable, Timothy Compton, Chief Strategy Officer at Alcami, shares his perspective on why sponsors are increasingly looking for partners with deeper, modality-specific expertise. As therapeutic pipelines become more diverse and manufacturing requirements more complex, Tim highlights the growing importance of specialized capabilities, strong regulatory track records, and partner networks built around reliability and performance. 👇 Read the full roundtable — link in the comments.

🛡️ Maintaining control of materials, systems and environments takes more than one service. See how 𝗔𝗹𝗰𝗮𝗺𝗶’𝘀 𝗣𝗵𝗮𝗿𝗺𝗮 𝗦𝘁𝗼𝗿𝗮𝗴𝗲 & 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀 connect them. ➡️

The most defensible lab studies are designed with the end in mind. Understanding how data will be questioned—by regulators, auditors, or internal stakeholders—helps teams avoid surprises later. Alcami’s lab services are built around anticipating review, supporting studies that are not only compliant but confidently defensible. Because preparation doesn’t start at submission—it starts at design. https://lnkd.in/e_JfDGgh #DefensibleData #RegulatoryScience #LabServices #Biopharma #Alcami

A method that performs well under controlled conditions may not withstand validation, transfer, or routine use. Reviewers often look beyond whether a method passed—and examine how it performs across expected variability, different analysts, and real-world conditions. When robustness isn’t adequately assessed early, teams may face rework later—often under tighter timelines. Alcami supports phase-appropriate method development and validation, helping identify potential robustness gaps before they become review findings. Because methods are evaluated over time, not just at approval. https://lnkd.in/ehJzzfrY #AnalyticalDevelopment #MethodValidation #LabServices #DataIntegrity #Biopharma